The
asymmetric hydrogenation of α,β-unsaturated carboxylic
acids using readily prepared bis(phosphine) cobalt(0) 1,5-cyclooctadiene
precatalysts is described. Di-, tri-, and tetra-substituted acrylic
acid derivatives with various substitution patterns as well as dehydro-α-amino acid derivatives were hydrogenated
with high yields and enantioselectivities, affording chiral carboxylic
acids including Naproxen, (S)-Flurbiprofen, and a d-DOPA precursor. Turnover numbers of up to 200 were routinely
obtained. Compatibility with common organic functional groups was observed with the reduced cobalt(0)
precatalysts, and protic solvents such as methanol and isopropanol
were identified as optimal. A series of bis(phosphine) cobalt(II)
bis(pivalate) complexes, which bear structural similarity to state-of-the-art
ruthenium(II) catalysts, were synthesized, characterized, and proved
catalytically competent. X-band EPR experiments revealed bis(phosphine)cobalt(II)
bis(carboxylate)s were generated in catalytic reactions and were identified
as catalyst resting states. Isolation and characterization of a cobalt(II)–substrate
complex from a stoichiometric reaction suggests that alkene insertion
into the cobalt hydride occurred in the presence of free carboxylic
acid, producing the same alkane enantiomer as that from the catalytic
reaction. Deuterium labeling studies established homolytic H2 (or D2) activation by Co(0) and cis addition of H2 (or D2) across alkene double bonds, reminiscent
of rhodium(I) catalysts but distinct from ruthenium(II) and nickel(II)
carboxylates that operate by heterolytic H2 cleavage pathways.